| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_559e79ffb3ad6326536ebc2e7607668f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_689d532e7f712c780cb4cec200f16fef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a189609129b71ac0dcf849e632b08b94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b9d2915f0da2a89a88cf736b9cb5933 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate |
2001-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3703502afe37e3c29504312e611b28be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3759faf797a58798b0475755054321ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d21af2243f5fef6a49e745406dc6841c |
| publicationDate |
2002-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0205808-A1 |
| titleOfInvention |
Novel methods and compositions for the treatment or prevention of dysmenorrhoea and menstrual side effects: the use of phospholipase inhibitors |
| abstract |
The present invention discloses the use of secretory phospholipases A2 inhibitors in compositions and in methods for modulation of uterine contractions and for reducing or alleviating discomforting symptoms such as pain and blood loss, for the treatment and/or prophylaxis of dysmenorrhoea and related conditions and for the treatment and/or prophylaxis of premature uterine expulsion of a foetus or embryo, impending abortion or miscarriage. |
| priorityDate |
2000-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |